Ambient particulate matter (PM) air pollution has been repeatedly observed to be associated with increased risk of hospital admissions and deaths attributed to cardiovascular causes in studies conducted throughout the industrialized world ([@b1-ehp0113-000978]; [@b7-ehp0113-000978]; [@b12-ehp0113-000978]; [@b16-ehp0113-000978]; [@b19-ehp0113-000978]; [@b33-ehp0113-000978]; [@b35-ehp0113-000978]; [@b50-ehp0113-000978]).

Similar relationships have been reported in locations reflecting a wide range of PM and of gaseous copollutant concentrations ([@b15-ehp0113-000978]; [@b20-ehp0113-000978]; [@b23-ehp0113-000978]; [@b45-ehp0113-000978]; [@b52-ehp0113-000978]). Other studies have shown that these associations are not confounded by secular time trends, seasonal patterns, influenza epidemics ([@b6-ehp0113-000978]), or weather ([@b36-ehp0113-000978]; [@b39-ehp0113-000978], [@b40-ehp0113-000978]). In addition, a large study of essentially every U.S. city reported that airborne particles were the only air pollutant that showed an independent effect on daily deaths, and that those gaseous air pollutants did not confound the association between PM and daily deaths ([@b35-ehp0113-000978]).

Although the association of airborne particles with cardiovascular events is clear, the mechanisms behind these associations are not fully understood. To further understanding of the mechanisms behind these observations, it is important to examine associations with more specific end points that may suggest specific pathways.

Recently, attention has focused on whether PM air pollution is a specific trigger of myocardial infarction (MI) \[*International Classification of Diseases*, Revision 9 (ICD-9), code 410 ([@b48-ehp0113-000978])\]. [@b30-ehp0113-000978] conducted a case-crossover study of 772 patients presenting to Boston area hospitals with strictly defined MI and reported that elevated concentrations of ambient PM \[fine PM with aerodynamic diameter \< 2.5 μm (PM~2.5~) and \< 10 μm (PM~10~)\] were strongly associated with higher risks of MI onset in the 2-hr period, and in the 24-hr period, preceding the event.

[@b11-ehp0113-000978] analyzed hospital admissions for MI in Rome with a case-crossover analysis and found a strong association with total suspended PM. In contrast, [@b44-ehp0113-000978] observed a slight effect of fine PM on onset of MI, but no association was found when stratified by those with and without heart disease. [@b25-ehp0113-000978] conducted a Poisson regression analysis of 19,460 hospital admissions for acute MI in southern California but did not observe an effect of PM~10~, although exposure measurements were recorded only every 6th day. [@b7-ehp0113-000978] conducted a multicity Poisson regression analysis and concluded that increased PM~10~ concentration increased the risk of death from MI.

To understand these disparate findings in isolated cities, a systematic approach is necessary. A systematic examination of the lag structure of the association is also needed. We therefore conducted a multicity case-crossover study of the acute effect of PM~10~ on the increased risk of being admitted to the hospital for MI among the elderly in 21 U.S. cities and whether that risk was modified by medical or demographic factors.

Materials and Methods
=====================

Health data.
------------

The data on hospital admissions were extracted from the Health Care Financing Administration (Medicare; Baltimore, MD) billing records, which we obtained for the years 1985--1999. The Medicare system provides hospital coverage for all U.S. citizens ≥ 65 years of age.

We analyzed data on persons who were admitted to the hospital with a primary diagnosis of MI (ICD-9 code 410) between 1986 and 1999. Medicare data provided personal characteristics such as age, sex, and race and the type of admission. Using this information, we selected only emergency admissions to ensure that these were new events and to better ascertain the timing of the event relative to air pollution exposure.

Using a unique identifier for each subject, we traced them through Medicare records to assess whether they had any primary or secondary diagnosis of atrial fibrillation (ICD-9 code 427.3), chronic obstructive pulmonary disease (COPD; ICD-9 code 490--496, except 493), diabetes (ICD-9 code 250), congestive heart failure (CHF; ICD-9 code 428) on previous admissions, and pneumonia (ICD-9 code 480--487) as secondary diagnoses on the index admission. These characteristics were examined as effect modifiers. These diagnoses have previously been suggested as modifiers of the cardiovascular effects of particles ([@b46-ehp0113-000978]; [@b51-ehp0113-000978]). Previous admissions were traced back to 1985, ensuring at least 1 year of data before the start of the particle data.

Daily monitoring of PM~10~ is not done in all U.S. cities. We selected the following 21 cities with daily monitoring of PM and representing a geographic distribution across the country: Birmingham, Alabama; Boulder, Colorado; Canton, Ohio; Chicago, Illinois; Cincinnati, Ohio; Cleveland, Ohio; Colorado Springs, Colorado; Columbus, Ohio; Denver, Colorado; Detroit, Michigan; Honolulu, Hawaii; Houston, Texas; Minneapolis--St. Paul, Minnesota; Nashville, Tennessee; New Haven, Connecticut; Pittsburgh, Pennsylvania; Provo-Orem, Utah; Salt Lake City, Utah; Seattle, Washington; Steubenville, Ohio; and Youngstown, Ohio.

For most cities, the metropolitan county encompassed the city and much of its suburbs, but we used multiple counties for Minneapolis-St. Paul (Ramsey and Hennepin, MN), Birmingham (Blount, Jefferson, St. Clair, Shelby, and Walker, AL), Steubenville (Jefferson, OH, and Brooke and Hancock, WV), and Youngstown (Columbiana and Mahoning, OH).

Environmental data.
-------------------

We obtained PM~10~ data from the U.S. Environmental Protection Agency's Aerometric Information Retrieval System ([@b27-ehp0113-000978]). Many of the cities have more than one monitoring location, requiring a method to average over multiple locations. We computed local daily mean PM~10~ concentrations using an algorithm that accounts for the different monitor-specific means and variances ([@b50-ehp0113-000978]). Not all cities have daily PM~10~ for the full range of years from 1986 to 1999; therefore, each city was analyzed for those years when daily PM~10~ was available.

These PM~10~ series had some occasional missing observations, and we replaced the missing values with the predicted values from a regression where we controlled for season and long-term trend, weather variables, and extinction coefficient, which has been shown to be a good predictor of fine particle concentrations ([@b29-ehp0113-000978]). The average percentage of observations replaced was 8.4%. We obtained local meteorologic data from the U.S. Surface Airways and Airways Solar Radiation hourly data ([@b26-ehp0113-000978]).

Analytical strategy.
--------------------

We investigated the association between daily PM~10~ concentrations and hospital admissions for MI using a case-crossover design. The case-crossover design was developed as a variant of the case--control design to study the effects of transient exposures on acute events ([@b24-ehp0113-000978]). This design samples only cases and compares each subject's exposure experience in a time period just before a case-defining event with that subject's exposure at other times. Because there is perfect matching on all measured or unmeasured subject characteristics that do not vary over time, there can be no confounding by those characteristics. If, in addition, the control days are chosen to be close to the event day, slowly varying subject characteristics are also controlled by matching.

[@b3-ehp0113-000978], [@b4-ehp0113-000978] demonstrated that by choosing control days close to event days, even very strong confounding of exposure by seasonal patterns could be controlled by design in the case--control approach. This makes the approach an attractive alternative to the Poisson models. [@b21-ehp0113-000978] showed that a time-stratified approach to choosing controls, such as sampling control days from the same month of the same year, avoided some subtle selection bias issues and resulted in a proper conditional logistic likelihood. [@b42-ehp0113-000978] recently demonstrated with simulation studies that this approach gave unbiased effect sizes and coverage probabilities even with strong seasonal confounding. We used this same stratified approach in our analysis. Matching on day of the week as well as season also controls for the possibility that the day of the week effect varies seasonally.

We defined the hazard period---when a person is at risk for the triggering of an acute MI---as the day of the patient's hospitalization. Air pollution has short-term serial correlation; to ensure that all of our control days were independent, we chose control days matched on day of the week, in the same month and year as the event day. The data were analyzed using a conditional logistic regression (PROC PHREG, release 8.2; SAS Institute, Cary, NC).

The analysis was conducted for each city separately, and we controlled for day of the week and weather. To control for potential impacts of weather, we used apparent temperature (AT) for the same and previous day, defined as an individual's perceived air temperature given the humidity. AT was calculated with the following formula ([@b18-ehp0113-000978]; [@b43-ehp0113-000978]):
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where *T*~*a*~ is air temperature and *T*~d~ is dew point temperature.

Because risk may vary nonlinearly with AT, we used a regression spline (with 3 df) for both the same day and the previous day. PM~10~ was modeled linearly. To confirm the report of [@b7-ehp0113-000978] that the association was predominant with PM~10~ on the day of the event, we examined effects at exposure from lag day 0 to lag day 2. If we could confirm a primary association with lag day 0, we used this for the subsequent analysis described below.

As a sensitivity analysis, we tested an alternate referent selection scheme that matched on AT (rounded to the same degrees Celsius) and used indicator variables to control for day of the week. Because matching on two covariates controls for interactions between the covariates, this controls for the possibility that the temperature effects vary by month. It also renders moot any question of whether the nonlinear dependence of MIs with temperature was modeled correctly. Previous day's temperature was controlled using a cubic spline in this analysis, as well.

Case-crossover analyses lend themselves to the analysis of effect modification. Factors such as sex are controlled by matching in the design of the study, but we can still test for effect modification with interaction terms or a stratified analysis. We chose stratified analyses, because if a characteristic modifies the effect of PM~10~, it might also modify the effect of weather or other covariates. A stratified analysis controls for this. Specifically, we conducted stratified analyses by sex, age (\< 75 vs. ≥ 75), and previous admission for chronic disease such as atrial fibrillation, COPD, CHF, and diabetes, and secondary diagnosis for pneumonia as an acute modifier.

In a second stage of the analysis, the city-specific results were combined using the multivariate meta-regression technique of [@b5-ehp0113-000978]. To be conservative, we report the results incorporating a random effect, whether or not there was a significant heterogeneity.

Finally, we assessed the shape of the dose--response relationship by fitting a piecewise linear spline, with slope changes at 20 μg/m^3^ and 50 μg/m^3^. We combined these estimates using a random effect meta-analysis as well.

Results
=======

There were 302,453 hospital admissions for MI in the 21 cities during the study period. [Table 1](#t1-ehp0113-000978){ref-type="table"} shows the counts for all of the cities broken into categories by age group, sex, and previous and secondary diagnosis. [Table 2](#t2-ehp0113-000978){ref-type="table"} shows the distribution of environmental factors by city, including the study period, the total population, PM, AT, and the counts of hospital admissions for MI. The average PM~10~ across all cities was 27 μg/m^3^.

We first looked at the lag structure of the association between PM~10~ and the risk of hospitalization for MI by simultaneously estimating the effect of PM~10~ from lag days 0 to 2. The combined estimates of percent change in risk \[and 95% confidence interval (CI)\] of emergency hospitalization for MI are shown in [Figure 1](#f1-ehp0113-000978){ref-type="fig"} together with the estimate of lag day 0 alone. The PM~10~ effect is mainly associated with the change in risk on the day of hospitalization; therefore, the rest of the analysis was done for lag day 0. [Figure 1](#f1-ehp0113-000978){ref-type="fig"} also shows the percent change of the combined estimates for PM~10~ at lag day 0 from the sensitivity analysis, where the control periods were chosen using the same time-stratified approach but such that exposures on the case day were compared with exposures occurring on days of the same month with the same value of AT (TEMP) as the case day.

The results shown in [Figure 1](#f1-ehp0113-000978){ref-type="fig"} using the two different referent selection schemes are consistent and show a very similar estimated effect. Overall, we found that for each 10 μg/m^3^ increase in the concentration of PM~10~, there was a 0.65% (95% CI, 0.3--1%) increase in the risk of hospitalization for an MI among the study population. When matching by AT (TEMP in [Figure 1](#f1-ehp0113-000978){ref-type="fig"}), we found a 0.64% (95% CI, 0.1--1.2%) increase. There was no evidence that the variation in effects size estimates by city was greater than would be expected giving their standard errors, with a chi-square value for heterogeneity of 17.8 (21 df, *p* = 0.6).

[Figure 2](#f2-ehp0113-000978){ref-type="fig"} shows the results of the stratified analysis to examine effect modification by age group, sex, and previous admissions for atrial fibrillation, COPD, CHF, and diabetes and secondary diagnosis for pneumonia. We did not find a statistically significant modification of effect, but we found that acute or chronic lower respiratory disease had important effects on response to PM~10~. In subjects with a previous admission for COPD, we found a 1.3% change (95% CI, −0.1 to 2.8) for a 10 μg/m^3^ increase in PM~10~ in the risk of hospitalization for MI, whereas the risk was halved in subjects without a previous admission for COPD (0.6%, 95% CI, 0.3--1). In subjects with a secondary diagnosis of pneumonia, we found a 1.4% change (95% CI, −0.8 to 3.6) in the risk of hospitalization for MI, compared with a 0.6% change (95% CI, 0.3--1) in subjects without a secondary diagnosis of pneumonia. No significant heterogeneity was found when combining the stratified results.

None of the other effect modifiers we examined (age, sex, CHF, atrial fibrillation, diabetes) showed much evidence for effect modification except perhaps for sex, with a suggestive difference for males (0.9%; 95% CI, 0.2--1.6) versus females (0.5%; 95% CI, 0.05--1.97).

Finally, the shape of the exposure--response relationship between MI hospitalizations and PM~10~ is shown in [Figure 3](#f3-ehp0113-000978){ref-type="fig"}. The exposure response is almost linear, but with a steeper slope at levels of PM~10~ \< 50 μg/m^3^.

Discussion
==========

We found a significant association between airborne particles and the risk of emergency MI hospitalization in a large multicity study. This association was only with PM~10~ on the same day, suggesting that airborne particles are acting as a trigger of an MI. We did not find evidence of effect modification by age, and weak evidence by sex, but we found a doubled risk in subjects with a secondary diagnosis of pneumonia or a previous admission for COPD. Diabetes, CHF, and atrial fibrillation did not modify the risk. These results greatly expand the number of locations in which an association between PM~10~ and MIs has been investigated and, by using a uniform analytical strategy, provide a clearer indication of the lag between exposure and response.

The estimated effect for a 10 μg/m^3^ increase in PM~10~ on emergency MI admissions (0.65%; 95% CI, 0.3--1.0) was higher than the estimates recently published for all-cause mortality ([@b42-ehp0113-000978]). This suggests that MI is a more specific outcome, and the lag structure found indicates a rapid pathway. In the same article ([@b42-ehp0113-000978]), we also showed that the effects of PM~10~ on hospital admissions for all other cardiovascular causes are not greatly different from the effects on MI admissions.

Recent studies of intermediate markers also provide support for a causal association. These include an observation of increased plasma viscosity ([@b31-ehp0113-000978]) and increased plasma fibrinogen in a human exposure chamber study ([@b14-ehp0113-000978]). Results for C-reactive protein concentrations have been mixed ([@b8-ehp0113-000978]; [@b13-ehp0113-000978]; [@b32-ehp0113-000978]; [@b34-ehp0113-000978]), but PM exposure was associated with decreased plaque stability in an animal model for arteriosclerosis ([@b47-ehp0113-000978]). In a Los Angeles panel study in patients with COPD ([@b22-ehp0113-000978]) and in a large cross-sectional German study of older adults ([@b17-ehp0113-000978]), higher levels of air pollution were associated with higher blood pressure. Another study in Boston ([@b49-ehp0113-000978]) suggested that changes in PM~2.5~ led to within-person increases in resting and exercise blood pressure among vulnerable patients with cardiovascular disease. These studies provide a limited but growing understanding of mechanisms underlying these findings, suggesting that pollution may lead to acute or chronic vasoconstriction and/or atherosclerosis, perhaps due to systemic inflammation, changes in autonomic function, or oxidative stress.

Our finding that secondary diagnosis of pneumonia or a previous admission for COPD appears to increase the risk is consistent with previous findings. For example, cardiovascular deaths on high-pollution days have been reported to be three times as likely to include respiratory complications ([@b38-ehp0113-000978]). In a study using Poisson models, we found that a secondary diagnosis for acute respiratory infection, acute bronchitis, pneumonia, and COPD modified the risk of any admission for heart disease ([@b51-ehp0113-000978]). [@b11-ehp0113-000978] also analyzed several comorbidities, and they did not find effect modification. Their study showed some indication of a higher effect for conduction disorders, a slightly higher effect in females, and a higher effect with increasing age group.

Previous studies have reported PM~10~ ([@b2-ehp0113-000978]; [@b28-ehp0113-000978]; [@b50-ehp0113-000978]) effects on respiratory admissions. However, the small percentage increase in pneumonia associated with a 10 μg/m^3^ increase in PM~10~ cannot explain the doubling of the effect of PM~10~ on MI admissions. Persons with COPD often have underlying coronary artery disease through their joint association with smoking, and this may explain some or all of the observed effect modification. We also did not find effect modification by sex and age, even if we found a slightly higher effect in males. The weak evidence for effect modification by age groups indicates that the adverse effect of particles is not limited to the extremely elderly population.

The indication of a somewhat higher slope at PM~10~ concentrations \< 50 μg/m^3^ is consistent with a previous report for all-cause mortality ([@b40-ehp0113-000978]). Other studies have assessed exposure response for particle using nonparametric smoothing ([@b37-ehp0113-000978]; [@b41-ehp0113-000978]) or natural spline ([@b10-ehp0113-000978]) and similarly found little evidence for a threshold and more support for steeper slopes at low concentrations.

There is a substantial body of epidemiologic literature showing a clear and consistent association between concentrations of ambient PM and negative health effects ([@b1-ehp0113-000978]; [@b9-ehp0113-000978]; [@b12-ehp0113-000978]; [@b19-ehp0113-000978]; [@b35-ehp0113-000978]). Less clear is the biologic mechanism by which PM could be causing this morbidity and mortality. One avenue by which investigators can offer direction is identifying which outcomes are most strongly and consistently associated with PM~10~ and conditions that modify that outcome. Epidemiologic research continues to narrow the focus around specific outcomes, from mortality to cause-specific mortality and from hospitalization for cardiovascular disease to MI and examination of specific modifiers.

The further epidemiologic identification of individual traits that are associated with increased risk of mortality and morbidity from increased concentrations of PM air pollution will continue to direct ongoing research into the biologic mechanism and provide critical data for risk assessment and inform policy makers.

This study was funded by the U.S. Environmental Protection Agency (EPA)/Harvard Center on Ambient Particle Health Effects EPA Particulate Matter Center (EPA grant R827353 and National Institute of Environmental Health Sciences grant ES0002).
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![Combined random-effect estimated change in risk (and 95% CI) of hospitalization for MI associated with a 10 μg/m^3^ increase in daily PM~10~ on the same day and for lag days 0--2. Results are shown for our main model and (only for lag day 0) for the referent selection scheme that matched on AT (TEMP).](ehp0113-000978f1){#f1-ehp0113-000978}

![Stratified analysis for several effect modifiers: combined random-effect estimated change in risk (and 95% CI) of hospitalization for MI associated with a 10 μg/m^3^ increase in daily PM~10~ on the same day. W/out, without.](ehp0113-000978f2){#f2-ehp0113-000978}

![Combined random-effect estimated of the dose--response relationship between MI emergency hospital admissions and PM~10~, computed by fitting a piecewise linear spline, with slope changes at 20 μg/m^3^ and 50 μg/m^3^.](ehp0113-000978f3){#f3-ehp0113-000978}

###### 

Counts of hospital admissions for MI in total and by age group, sex, secondary diagnoses, and previous admissions among residents of 21 U.S. cities.

  Variable               No. of events (%)
  ---------------------- -------------------
  MI                     302,453
  Age (years)            
   65--75                145,983 (48)
   \> 75                 156,470 (52)
  Sex                    
   Male                  147,246 (49)
   Female                155,207 (51)
  Secondary diagnosis    
   Pneumonia             13,588 (4)
  Previous admissions    
   COPD                  32,455 (11)
   Atrial fibrillation   28,912 (10)
   Diabetes              49,732 (16)

###### 

Counts of hospital admissions for MI and distribution of environmental factors.

                                                         AT      PM~10~                           
  ---------------------- ------------ --------- -------- ------- -------- ------- ------- ------- -------
  Birmingham, AL         1986--1993   14,457    662      2.9     17.2     30.5    13.7    32.3    63.2
  Boulder, CO            1989--1996   1,347     291      −4.3    8.0      20.9    10.2    20.3    37.9
  Canton, OH             1989--1996   7,158     378      −5.1    8.2      24.6    14.8    24.3    43.5
  Chicago, IL            1986--1999   67,974    5,377    −5.0    8.3      26.0    16.8    32.1    57.6
  Cincinnati, OH         1989--1998   13,025    845      −3.1    10.9     27.1    16.3    28.5    52.5
  Cleveland, OH          1989--1999   27,218    1,394    −4.2    9.1      25.4    17.0    34.1    63.4
  Colorado Springs, CO   1987--1996   2,398     517      −4.3    7.1      19.4    12.4    21.7    40.1
  Columbus, OH           1991--1994   12,451    1,069    −3.1    10.7     26.7    15.4    25.7    46.5
  Denver, CO             1986--1999   4,755     555      −4.1    7.6      21.5    16.7    28.5    49.2
  Detroit, MI            1986--1999   30,793    2,061    −4.8    8.3      25.4    13.1    30.5    59.8
  Honolulu, HI           1998--1999   6,540     876      23.7    26.8     29.6    11.1    15.5    22.7
  Houston, TX            1986--1987   15,085    3,401    7.8     23.2     34.3    15.9    29.7    50.0
  Minneapolis, MN        1986--1999   14,356    1,627    −8.5    6.4      24.1    12.0    23.5    44.4
  Nashville, TN          1990--1999   4,740     570      0.7     15.3     30.1    15.7    28.1    46.5
  New Haven, CT          1988--1999   12,807    824      −3.6    8.6      25.1    9.9     22.7    44.8
  Pittsburgh, PA         1987--1998   34,439    1,282    −3.6    9.6      25.3    11.6    26.0    60.0
  Provo/Orem, UT         1986--1999   815       369      −4.1    7.6      23.9    14.5    30.5    66.9
  Salt Lake City, UT     1986--1999   3,694     898      −4.3    7.6      24.1    13.9    30.7    61.2
  Seattle, WA            1986--1997   12,437    1,737    1.9     9.2      18.1    12.4    24.5    50.5
  Steubenville, OH       1988--1998   4,185     132      −3.6    9.5      25.2    15.4    30.0    59.7
  Youngstown, OH         1989--1995   9,493     370      −5.2    7.9      23.9    15.4    27.9    50.7
  Total                               300,167   25,340   −1.70   11.36    26.55   14.70   28.35   53.55
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